Markets:

Overview

News

Currencies

International

Treasuries

iShares Biotechnology ETF (NQ:IBB)

172.41 -4.33 (-2.45%)

Streaming Delayed Price Updated: 1:28 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2

...

21 22 23 24 25 26 27 28 Next >

Why Transportation (IYT) Must Hold Over $268 ↗

June 08, 2021

The transportation sector (IYT) bounced off $268 closing +.32% on the day.

Via Talk Markets

The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex ↗

June 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc...

Via Benzinga

Could CureVac Be a Millionaire-Maker Stock? ↗

June 08, 2021

This biotech's coronavirus vaccine candidate could be the next to hit the market -- but a lot of its potential success has been priced in.

Via The Motley Fool

A Fresh Dose of Biotech Perspective ↗

May 30, 2021

If the only thing that’s changed with your favorite biotech is the price, stay the course. Your bottom line will thank you for it later.

Via Talk Markets

Small-Cap Growth Stocks ↗

June 07, 2021

VBK, which began trading in 2004, rose with the market until the 2008 financial crisis. However, since the spring of 2009, VBK has been in a monstrous uptrend.

Via Talk Markets

5 Top ETFs With Exposure To Biogen ↗

June 07, 2021

Here is a look at five ETFs with large exposure to Biogen shares.

Via Talk Markets

5 Top ETFs With Exposure To Biogen ↗

June 07, 2021

For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that...

Via Benzinga

'Fast Money Halftime Report' Picks For June 7 ↗

June 07, 2021

On CNBC's "Fast Money Halftime Report," Joe Terranova said he would buy the breakout in iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) for a return to the February...

Via Benzinga

iShares Biotechnology Fund Spike Continues Rally, Nears Critical Resistance Level ↗

June 07, 2021

The iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) is making a big move higher, but there's a chance that the rally is about to end. The shares have reached a level that has...

Via Benzinga

The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck ↗

June 07, 2021

Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...

Via Benzinga

Can The Small Cap Index And The Transportation Sector Hold Key Support? ↗

June 06, 2021

For the small-cap Russell 2000 (IWM), $226.69 is an important level to hold as it shows the index can sustain itself over its main consolidation range dating back to early April.

Via Talk Markets

The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact ↗

June 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 3) BioCryst Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout ↗

June 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,...

Via Benzinga

How To Use Simple Risk Control For Stocks Like AMC ↗

June 03, 2021

Once a stock goes flying, it seems as though everyone wants a piece of the action. Of course, it might be fun to be a part of a big move, but it can also be extremely dangerous to take a trade in...

Via Talk Markets

The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements ↗

June 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates ↗

June 01, 2021

The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive...

Via Benzinga

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗

May 31, 2021

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...

Via Benzinga

Cybersecurity-An Ever-Evolving Megatrend ↗

May 30, 2021

As this year’s tech boom in the U.S economy started with the surge in prices from pandemic lows, the demand for more security across several sectors has naturally grown.

Via Talk Markets

Topics Economy

The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq ↗

May 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) BioCryst Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs ↗

May 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)...

Via Benzinga

The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing ↗

May 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

Why the Russell 2000 (IWM) Needs to Clear $222.14 ↗

May 25, 2021

For the 3rd time, the small-cap index Russell 2000 (IWM) has failed to clear its 50-Day moving average.

Via Talk Markets

Medical Miracles Inside Biotech ETFs ↗

May 24, 2021

The events of the past year focused a lot of attention on game changing developments made possible by the global biotech industry. Of the major names Moderna is the one where the original research and...

Via Talk Markets

Topics Intellectual Property

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗

May 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company...

Via Benzinga

The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation ↗

May 23, 2021

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts....

Via Benzinga

As the Wind Blows ↗

May 23, 2021

US Equity markets are all in see-saw patterns now, pushing up and down into resistance and support.

Via Talk Markets

Will Monday Settle The Stock Market Divide? ↗

May 23, 2021

The only difference between a cautionary phase and a bullish phase is that the price is trading underneath the 50-DMA instead of trading over it. This week’s test for the S&P and the Dow was passed...

Via Talk Markets

Topics Stocks

The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying ↗

May 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc...

Via Benzinga

'Fast Money' Traders Weigh In On IBB And Gilead ↗

May 21, 2021

On CNBC's "Fast Money," Tim Seymour spoke about a possible break out in iShares Nasdaq Biotechnology ETF (NASDAQ: IBB). He said traders should be defensive in a high...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks ↗

May 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

< Previous 1 2

...

21 22 23 24 25 26 27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.